Recent Blog Articles
Close relationships with neighbors influence cardiovascular health in Black adults
Why play? Early games build bonds and brain
5 numbers linked to ideal heart health
Rating the drugs in drug ads
Postpartum anxiety is invisible, but common and treatable
The popularity of microdosing of psychedelics: What does the science say?
Pouring from an empty cup? Three ways to refill emotionally
Is pregnancy safe for everyone?
New pediatric guidelines on obesity in children and teens
Screening tests may save lives — so when is it time to stop?
Robert C. Meisner, MD
Contributor
Robert C. Meisner, MD, is the medical director of the ketamine service in the psychiatric neurotherapeutics program at McLean Hospital, and an attending psychiatrist in the acute psychiatric service at Massachusetts General Hospital. He graduated from Princeton summa cum laude and attended Harvard Medical School. He was a doctoral student in cultural anthropology at the Harvard Graduate School for Arts and Sciences, where he focused on child soldiering in Uganda under American anthropologist Arthur Kleinman. He received his early clinical training as a resident at Harvard in internal medicine, anesthesia, critical care, and pain. Dr. Meisner has written and lectured on a wide range of topics, from pediatric and collegiate mood disorders to the safe translation of ketamine research into evidence-based clinical practice. He has previously served on the administrative board of Harvard College, as acting resident dean at Harvard College’s Currier House, and on the faculty of arts and sciences at Harvard University.
